Probleme bei der Darstellung von ARIVA.DE?

  • Laden unsere Charts bei Ihnen nicht?
  • Wird unser Forum bei Ihnen nicht korrekt dargestellt?

Sie nutzen einen Adblocker, der hierfür verantwortlich ist. Hierauf hat ARIVA.DE leider keinen Einfluss. Bitte heben Sie die Blockierung von ARIVA.DE in Ihrem Adblocker auf.

Probleme bei der Darstellung von ARIVA.DE?

Top-Thema

16:34 Uhr
Aktien New York: Stabi­lisierung - Weitere Notenbank-​Reden, Konjunktur­daten

NEURONES: Growth up 14.8% in Q1 2017

Mittwoch, 10.05.2017 17:45

PRESS INFORMATION
Nanterre, May 10, 2017 (after the closing of the stock exchange)
Heading: 1st quarter 2017 revenues

Growth up 14.8% in Q1 2017

(in millions of euros) Q1 2016 Q1 2017 growth of which organic
Revenues 109 125.1 + 14.8% + 13.5%

Achievements

In the first quarter of 2016, the Group continued its solid growth, both organic (+ 13.5%) and overall (+ 14.8%).

The favorable calendar effect contributed to an operating income totaling 9.8% (*) of revenues at the end of March 2017.

Compared to the 2016 reference document (available at www.neurones.net), the financial situation did not experience any significant changes.

(*) unaudited and after inclusion of 0.2% of expenses related to free shares.

Outlook

A slight change in scope is probable during this year (from H1 onwards) and concerns low-profit activities.

NEURONES forecasts the following for FY 2017 (excluding external growth):

  • revenues of more than €480 million,
  • an operating profit of between 9% and 9.5% of revenues.

About NEURONES

With over 5,100 experts, the NEURONES group specializes in Consulting (Management, Organization and Digital) and IT Services (Infrastructures and Applications). It supports its clients in their digital transformation projects and in the outsourcing of their Information Systems.

Euronext Paris (Compartment B - NRO) - Enternext Tech 40

www.neurones.net

Press Relations:
Florence Gillier Communication
Sabine Grosdidier
Tel.: +33 (0)1 41 18 85 55
sabineg@fgcom.fr
 

NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
rp@neurones.net
Investor relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
investisseurs@neurones.net
 



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NEURONES via Globenewswire